General MedicationsORALLY DISINTEGRATINGStandard
CITALOPRAM HYDROBROMIDE
CITALOPRAM HYDROBROMIDE
Standard Dose
40MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 021763 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CITALOPRAM HYDROBROMIDE Form and strength TABLET; ORALLY DISINTEGRATING - 40MG Sponsor BIOVAIL LABS INTL Submission history Latest submission status date: 2005-12-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview CITALOPRAM HYDROBROMIDE is listed in Drugs@FDA under application 021763 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CITALOPRAM HYDROBROMIDE Form and strength TABLET; ORALLY DISINTEGRATING - 40MG Sponsor BIOVAIL LABS INTL Submission history Latest submission status date: 2005-12-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.